Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Financial Results
US company ImmuCell has seen its share price drop to its lowest level since 2017.
Covetrus shares have fallen to their lowest value since the company started trading on the stock market earlier this year.
UK aquaculture health firm Benchmark is continuing to face challenges in the global shrimp and Mediterranean seabass/bream markets.
Covetrus has posted sales of around $1 billion for the second quarter of 2019, representing a flat year-on-year comparison.
Elanco's second-quarter revenues have been impacted by foreign currency exchange rates and the firm has scaled back its full-year forecast due to African swine fever (ASF).
ImmuCell has seen its sales drop in Q2 2019, after previously recording its "best quarter ever".
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.